GLIMECHECK MV 0.3

Glimecheck MV 0.3 Tablet is a triple combination antidiabetic medication containing Glimepiride, Metformin, and Voglibose 0.3 mg. This formulation is designed for effective management of Type 2 Diabetes Mellitus, especially in patients who require multiple mechanisms to control high blood sugar levels.

It works by enhancing insulin secretion, improving insulin sensitivity, and slowing carbohydrate absorption in the intestines.

Key Benefits:

• Offers multi-targeted blood sugar control

• Glimepiride: Stimulates insulin secretion from the pancreas

• Metformin: Decreases glucose production and increases peripheral uptake

• Voglibose 0.3 mg: Delays glucose absorption, reducing post-meal sugar spikes

• Helps reduce HbA1c levels for long-term diabetes management